Insider filing report for Changes in Beneficial Ownership
- Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
- Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
13G/A5
Under the
Securities Exchange Act of 1934
(Amendment
No. 5)*
SciClone
Pharmaceuticals, Inc.
(Name of
Issuer)
Common
Stock, Par Value $0.001 per share
(Title of
Class of Securities)
80862K104
(CUSIP
Number)
December
31, 2007
(Date of
Event which Requires Filing of this Statement)
Check the
appropriate box to designate the rule pursuant
to which
this Schedule is filed:
o Rule
13d-1(b)
o Rule
13d-1(d)
*The
remainder of this cover page shall be filled out for a reporting person’s
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The
information required in the remainder of this cover page shall not be deemed to
be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934
(“Act”) or otherwise subject to the liabilities of that section of the Act but
shall be subject to all other provisions of the Act (however, see the
Notes).
|
1.
|
Names
of Reporting Persons.
I.R.S.
Identification Nos. of above persons (entities only).
Claudio
Cavazza
|
||
|
2.
|
Check
the Appropriate Box if a Member of a Group
(See
Instructions)
160;
(a) o
160;
(b) o
|
||
|
3.
|
SEC
Use Only
|
||
|
4.
|
Citizenship
or Place of Organization
Italy
|
||
|
5.
|
Sole
Voting Power
394,615
|
||
|
Number
of
Shares
Beneficially
|
6.
|
Shared
Voting Power
6,394,988
|
|
|
Owned
by Each
Reporting
Person
With:
|
7.
|
Sole
Dispositive Power
394,615
|
|
|
8.
|
Shared
Dispositive Power
6,394,988
|
||
|
9.
|
Aggregate
Amount Beneficially Owned by Each Reporting Person
6,789,603
(as of December 31, 2007)
|
||
|
10.
|
Check
box if the Aggregate Amount in Row (9) Excludes
Certain
Shares (See
Instructions)
160;
o
|
||
|
11.
|
Percent
of Class Represented by Amount in Row (9)
14.7%
(based upon 46,114,562 shares of Common Stock outstanding as of October
31, 2007, as reported in the Issuer’s Quarterly Report on Form 10-Q for
the quarter ended September 30, 2007 filed with the U.S. Securities and
Exchange Commission on November 9, 2007).
|
||
|
12.
|
Type
of Reporting Person (See Instructions)
IN
|
||
-2-
|
Item
1(a).
|
Name
of Issuer:
|
SciClone
Pharmaceuticals, Inc.
|
Item
1(b).
|
Address
of Issuer’s Principal Executive
Offices:
|
901
Mariner’s Island Boulevard, Suite 205, San Mateo, CA 94404
|
Item
2(a).
|
Name
of Person Filing:
|
Claudio
Cavazza
|
Item
2(b).
|
Address
of Principal Business Office:
|
Via
Sudafrica, 20
Rome,
Italy 00144
|
Item
2(c).
|
Citizenship:
|
Italian
Citizen
|
Item
2(d).
|
Title
of Class of Securities:
|
Common
Stock, par value $0.001 per share (the “Shares”)
|
Item
2(e).
|
CUSIP
Number:
|
80862K104
|
Item
3.
|
If
this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c),
check whether the person is a:
|
This Item
3 is not applicable
-3-
|
Item
4.
|
Ownership:
|
|
(a)
|
Amount
beneficially owned:
|
6,789,603
|
|
(b)
|
Percent
of class:
|
14.7%
|
|
(c)
|
Number
of shares as to which such person has:
|
|
|
(i) sole
power to vote or to direct the vote:
|
394,615
|
|
|
(ii) shared
power to vote or to direct the vote:
|
6,394,988
|
|
|
(iii) sole
power to dispose or to direct the disposition of:
|
394,615
|
|
|
(iv) shared
power to dispose or to direct the disposition of:
|
6,394,988
|
|
Item
5.
|
Ownership
of Five Percent or Less of a Class:
|
Not
Applicable
|
Item
6.
|
Ownership
of More than Five Percent on Behalf of Another
Person:
|
Not
Applicable
|
Item
7.
|
Identification
and Classification of the Subsidiary Which Acquired the Security Being
Reported on by the Parent Holding
Company:
|
Not
Applicable
|
Item
8.
|
Identification
and Classification of Members of the
Group:
|
Not
Applicable
|
Item
9.
|
Notice
of Dissolution of Group:
|
Not
Applicable
|
Item
10.
|
Certification:
|
By
signing below, I certify that, to the best of my knowledge and belief, the
securities referred to above were acquired and are held in the ordinary course
of business and were not acquired and are not held for the purpose of or with
the effect of changing or influencing the control of the issuer of the
securities and were not acquired and are not held in connection with or as a
participant in any transaction having that purpose or effect.
-4-
SIGNATURE
After
reasonable inquiry and to the best of my knowledge and belief, I certify that
the information set forth in this statement is true, complete and
correct.
Dated:
February 13, 2008
CLAUDIO
CAVAZZA
By: /s/ Antonio
Nicolai
Name: Antonio
Nicolai
Title:
proxy holder authorized
This
Schedule 13G was signed under a Power-of-Attorney incorporated by reference to
Form 4s filed April 1, 2005
-5-